{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T13:06:17Z","timestamp":1794315977897,"version":"4.9.0"},"reference-count":67,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T00:00:00Z","timestamp":1746144000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurosci."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Aging is the primary risk factor for sporadic Alzheimer's disease. Chronic low-grade inflammation associated with aging drives cognitive impairment through multiple mechanisms involving oxidative stress, insulin resistance, and dysregulation of metabolic, immunologic, and hematologic systems.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In a 7-month, randomized, double-blind, placebo-controlled trial (NCT04669028), we investigated the safety and activity of bezisterim, a first-in-class, oral, blood\u2013brain barrier\u2013permeable, anti-inflammatory agent on cognitive, molecular, biochemical, physiological, and biological aging parameters in a subset of 50 mild-to-moderate probable Alzheimer's disease participants. These participants had source-document-verified clinical measures and samples, and they completed the protocol. This study focuses on epigenetic, metabolic, biomarker, and cognitive measures in the exploratory biomarker population that completed the protocol.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Bezisterim was associated with non-significant directional improvements in multiple measures of cognitive and functional performance compared to placebo, with correlations to biological age (determined by DNA methylation \u201cclocks\u201d) and to metabolism, inflammation, and dementia biomarkers. In addition, clinical measures correlated with the extent of DNA methylation of certain cytosine-phosphate-guanine (CpG) sites in genes associated with metabolic inflammation and neurodegeneration.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>The results suggest the possible use of bezisterim to target the multifactorial processes underlying dementia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Clinical trial registration<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link>https:\/\/clinicaltrials.gov\/study\/NCT04669028<\/jats:ext-link>\n                      , Identifier: NCT04669028.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fnins.2025.1516746","type":"journal-article","created":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T09:18:51Z","timestamp":1746177531000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":12,"title":["An exploratory analysis of bezisterim treatment associated with decreased biological age acceleration, and improved clinical measure and biomarker changes in mild-to-moderate probable Alzheimer's disease"],"prefix":"10.3389","volume":"19","author":[{"given":"Christopher L.","family":"Reading","sequence":"first","affiliation":[{"name":"BioVie Inc.","place":["Carson City, NV, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayan","family":"Yan","sequence":"additional","affiliation":[{"name":"BioVie Inc.","place":["Carson City, NV, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcia A.","family":"Testa","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Harvard T. H. Chan School of Public Health","place":["Boston, MA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald C.","family":"Simonson","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Diabetes, and Hypertension, Brigham and Women's Hospital, Harvard Medical School","place":["Boston, MA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hira","family":"Javaid","sequence":"additional","affiliation":[{"name":"Hurdle.bio\/Chronomics Ltd.","place":["London, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Schmunk","sequence":"additional","affiliation":[{"name":"Hurdle.bio\/Chronomics Ltd.","place":["London, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel E.","family":"Martin-Herranz","sequence":"additional","affiliation":[{"name":"Hurdle.bio\/Chronomics Ltd.","place":["London, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Brooke","sequence":"additional","affiliation":[{"name":"Epigenetic Clock Development Foundation","place":["Torrance, CA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juozas","family":"Gordevicius","sequence":"additional","affiliation":[{"name":"Epigenetic Clock Development Foundation","place":["Torrance, CA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Zhang","sequence":"additional","affiliation":[{"name":"Princeton Pharmatech","place":["Princeton, NJ, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harvey","family":"Yuan","sequence":"additional","affiliation":[{"name":"Princeton Pharmatech","place":["Princeton, NJ, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clarence","family":"Ahlem","sequence":"additional","affiliation":[{"name":"BioVie Inc.","place":["Carson City, NV, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lixia","family":"Wang","sequence":"additional","affiliation":[{"name":"BioVie Inc.","place":["Carson City, NV, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Penelope","family":"Markham","sequence":"additional","affiliation":[{"name":"BioVie Inc.","place":["Carson City, NV, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nily","family":"Osman","sequence":"additional","affiliation":[{"name":"BioVie Inc.","place":["Carson City, NV, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"O'Quinn","sequence":"additional","affiliation":[{"name":"BioVie Inc.","place":["Carson City, NV, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Palumbo","sequence":"additional","affiliation":[{"name":"BioVie Inc.","place":["Carson City, NV, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,5,2]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.jsbmb.2011.04.010","article-title":"Pharmacology and immune modulating properties of 5-androstene-3beta,7beta,17beta-triol, a DHEA metabolite in the human metabolome","volume":"126","author":"Ahlem","year":"","journal-title":"J. Steroid Biochem. Mol. Biol"},{"key":"B2","first-page":"119","article-title":"Studies of the pharmacology of 17alpha-ethynyl-androst-5-ene-3beta,7beta,17beta-triol, a synthetic anti-inflammatory androstene","volume":"4","author":"Ahlem","year":"","journal-title":"Int. J. Clin. Exp. Med"},{"key":"B3","doi-asserted-by":"publisher","first-page":"6451","DOI":"10.1038\/s41380-021-01103-3","article-title":"CCL5 promotion of bioenergy metabolism is crucial for hippocampal synapse complex and memory formation","volume":"26","author":"Ajoy","year":"2021","journal-title":"Mol. Psychiatry"},{"key":"B4","doi-asserted-by":"publisher","first-page":"e3002359","DOI":"10.1371\/journal.pbio.3002359","article-title":"Diet-induced glial insulin resistance impairs the clearance of neuronal debris in Drosophila brain","volume":"21","author":"Alassaf","year":"2023","journal-title":"PLoS Biol"},{"key":"B5","unstructured":"\u201cSafety and pharmacokinetics of anti-inflammatory NE3107 treatment in carbidopa\/levodopa-treatedpatients with Parkinson's disease: a phase 2a, double-blind, placebo-controlled study,\u201d\n          \n          \n            \n              Aldred\n              J.\n            \n            \n              Rodriguez\n              R.\n            \n            \n              Rivera-Rivera\n              E. J.\n            \n            \n              Issaacson\n              S. H.\n            \n            \n              Kumar\n              R.\n            \n            \n              Ellenbogen\n              A. L.\n            \n          \n          International Congress of Parkinson's Disease and Movement Disorders, Copenhagen, Denmark"},{"key":"B6","unstructured":"\u201cA randomized, phase 2a, double-blind, placebo-controlled clinical trial with NE3107 adjunctive to carbidopa\/levodopa in patients with Parkinson's disease,\u201d\n          \n          \n            \n              Aldred\n              J.\n            \n            \n              Rodriguez\n              R.\n            \n            \n              Rivera-Rivera\n              E. J.\n            \n            \n              Issaacson\n              S. H.\n            \n            \n              Kumar\n              R.\n            \n            \n              Ellenbogen\n              A. L.\n            \n          \n          International Congress of Parkinson's Disease and Movement Disorders, Copenhagen, Denmark"},{"key":"B7","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1038\/oby.2010.204","article-title":"potential role for 5-androstene-3beta,7beta,17beta-triol in obesity and metabolic syndrome","volume":"19","author":"Auci","year":"2011","journal-title":"Obesity"},{"key":"B8","doi-asserted-by":"publisher","first-page":"197","DOI":"10.14283\/jpad.2022.30","article-title":"Two randomized phase 3 studies of aducanumab in early Alzheimer's disease","volume":"9","author":"Budd Haeberlein","year":"2022","journal-title":"J. Prev. Alzheimers Dis"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1002\/jnr.24829","article-title":"Extracellular signal-regulated kinase regulates microglial immune responses in Alzheimer's disease","volume":"99","author":"Chen","year":"2021","journal-title":"J. Neurosci. Res"},{"key":"B10","doi-asserted-by":"publisher","first-page":"9036","DOI":"10.3390\/ijms21239036","article-title":"Danger-sensing\/Patten recognition receptors and neuroinflammation in Alzheimer's disease","volume":"21","author":"Chiarini","year":"2020","journal-title":"Int. J. Mol. Sci"},{"key":"B11","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s12974-024-03070-2","article-title":"Hypoxia inducible factor-1alpha regulates microglial innate immune memory and the pathology of Parkinson's disease","volume":"21","author":"Dong","year":"2024","journal-title":"J. Neuroinflammation"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1016\/S0092-8674(00)00210-5","article-title":"TNF-alpha induction by LPS is regulated posttranscriptionally via a Tpl2\/ERK-dependent pathway","volume":"103","author":"Dumitru","year":"2000","journal-title":"Cell"},{"key":"B13","doi-asserted-by":"publisher","first-page":"329","DOI":"10.3389\/fncel.2018.00329","article-title":"ACP. Role of microglia TLRs in neurodegeneration","volume":"12","author":"Fiebich","year":"2018","journal-title":"Front. Cell. Neurosci"},{"key":"B14","doi-asserted-by":"publisher","first-page":"6128","DOI":"10.3390\/ijms21176128","article-title":"Tumor necrosis factor alpha influences phenotypic plasticity and promotes epigenetic changes in human basal forebrain cholinergic neuroblasts","volume":"21","author":"Guarnieri","year":"2020","journal-title":"Int. J. Mol. Sci"},{"key":"B15","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.molcel.2012.10.016","article-title":"Genome-wide methylation profiles reveal quantitative views of human aging rates","volume":"49","author":"Hannum","year":"2013","journal-title":"Mol. Cell"},{"key":"B16","doi-asserted-by":"publisher","first-page":"e39027","DOI":"10.1097\/MD.0000000000039027","article-title":"A phase 2, open-label study of anti-inflammatory NE3107 in patients with dementias","volume":"103","author":"Haroon","year":"2024","journal-title":"Medicine"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.18632\/aging.101508","article-title":"Epigenetic clock for skin and blood cells applied to Hutchinson Gilford Progeria Syndrome and ex vivo studies","volume":"10","author":"Horvath","year":"2018","journal-title":"Aging"},{"key":"B18","doi-asserted-by":"publisher","first-page":"11984","DOI":"10.18632\/oncotarget.7453","article-title":"CCR5 deficiency accelerates lipopolysaccharide-induced astrogliosis, amyloid-beta deposit and impaired memory function","volume":"7","author":"Hwang","year":"2016","journal-title":"Oncotarget"},{"key":"B19","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1038\/sj.bjp.0706909","article-title":"RANTES stimulates Ca2+ mobilization and inositol trisphosphate (IP3) formation in cells transfected with G protein-coupled receptor 75","volume":"149","author":"Ignatov","year":"2006","journal-title":"Br. J. Pharmacol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"e0263190","DOI":"10.1371\/journal.pone.0263190","article-title":"Short communication: TNF-alpha and IGF-1 regulates epigenetic mechanisms of HDAC2 and HDAC10","volume":"17","author":"Jiang","year":"2022","journal-title":"PLoS ONE"},{"key":"B21","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1038\/s41591-020-0815-6","article-title":"Large-scale proteomic analysis of Alzheimer's disease brain and cerebrospinal fluid reveals early changes in energy metabolism associated with microglia and astrocyte activation","volume":"26","author":"Johnson","year":"2020","journal-title":"Nat. Med"},{"key":"B22","doi-asserted-by":"publisher","first-page":"5744","DOI":"10.1167\/iovs.14-14672","article-title":"HE3286 reduces axonal loss and preserves retinal ganglion cell function in experimental optic neuritis","volume":"55","author":"Khan","year":"2014","journal-title":"Invest. Ophthalmol. Vis. Sci"},{"key":"B23","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/s41572-021-00269-y","article-title":"Alzheimer disease","volume":"7","author":"Knopman","year":"2021","journal-title":"Nat Rev Dis Primers"},{"key":"B24","doi-asserted-by":"publisher","first-page":"45","DOI":"10.3389\/fnins.2017.00045","article-title":"Oral delivery of a synthetic sterol reduces axonopathy and inflammation in a rodent model of glaucoma","volume":"11","author":"Lambert","year":"2017","journal-title":"Front. Neurosci"},{"key":"B25","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.neuint.2017.03.002","article-title":"Blockade of CCR5 receptor prevents M2 microglia phenotype in a microglia-glioma paradigm","volume":"108","author":"Laudati","year":"2017","journal-title":"Neurochem. Int"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1002\/stem.1125","article-title":"Soluble CCL5 derived from bone marrow-derived mesenchymal stem cells and activated by amyloid beta ameliorates Alzheimer's disease in mice by recruiting bone marrow-induced microglia immune responses","volume":"30","author":"Lee","year":"2012","journal-title":"Stem Cells"},{"key":"B27","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.nlm.2009.04.003","article-title":"CCR5 deficiency induces astrocyte activation, Abeta deposit and impaired memory function","volume":"92","author":"Lee","year":"2009","journal-title":"Neurobiol. Learn. Mem"},{"key":"B28","doi-asserted-by":"publisher","first-page":"573","DOI":"10.18632\/aging.101414","article-title":"An epigenetic biomarker of aging for lifespan and healthspan","volume":"10","author":"Levine","year":"2018","journal-title":"Aging"},{"key":"B29","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3389\/fnagi.2019.00209","article-title":"Entanglement of CCR5 and Alzheimer's disease","volume":"11","author":"Li","year":"2019","journal-title":"Front. Aging Neurosci"},{"key":"B30","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s13195-022-01159-5","article-title":"Convergent transcriptomic and genomic evidence supporting a dysregulation of CXCL16 and CCL5 in Alzheimer's disease","volume":"15","author":"Li","year":"2023","journal-title":"Alzheimers. Res. Ther"},{"key":"B31","doi-asserted-by":"publisher","first-page":"2467","DOI":"10.1007\/s00125-013-3022-x","article-title":"The novel chemokine receptor, G-protein-coupled receptor 75, is expressed by islets and is coupled to stimulation of insulin secretion and improved glucose homeostasis","volume":"56","author":"Liu","year":"2013","journal-title":"Diabetologia"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1038\/onc.2011.308","article-title":"Phosphorylation of RelA\/p65 promotes DNMT-1 recruitment to chromatin and represses transcription of the tumor metastasis suppressor gene BRMS1","volume":"31","author":"Liu","year":"2012","journal-title":"Oncogene"},{"key":"B33","doi-asserted-by":"publisher","first-page":"303","DOI":"10.18632\/aging.101684","article-title":"DNA methylation GrimAge strongly predicts lifespan and healthspan","volume":"11","author":"Lu","year":"2019","journal-title":"Aging"},{"key":"B34","doi-asserted-by":"publisher","first-page":"E1036","DOI":"10.1152\/ajpendo.00668.2009","article-title":"A new antidiabetic compound attenuates inflammation and insulin resistance in Zucker diabetic fatty rats","volume":"298","author":"Lu","year":"2010","journal-title":"Am. J. Physiol. Endocrinol. Metab"},{"key":"B35","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1093\/jnen\/nlad071","article-title":"The intricate role of CCL5\/CCR5 axis in Alzheimer disease","volume":"82","author":"Ma","year":"2023","journal-title":"J. Neuropathol. Exp. Neurol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"101559","DOI":"10.1016\/j.isci.2020.101559","article-title":"Hippocampal 7alpha-hydroxylated neurosteroids are raised by training and bolster remote spatial memory with increase of the spine densities","volume":"23","author":"Maehata","year":"2020","journal-title":"iScience"},{"key":"B37","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1038\/s43587-021-00054-2","article-title":"Hypoxia compromises the mitochondrial metabolism of Alzheimer's disease microglia via HIF1","volume":"1","author":"March-Diaz","year":"2021","journal-title":"Nat Aging"},{"key":"B38","doi-asserted-by":"publisher","first-page":"3112","DOI":"10.2337\/db13-1783","article-title":"Task-induced brain activity patterns in type 2 diabetes: a potential biomarker for cognitive decline","volume":"63","author":"Marder","year":"2014","journal-title":"Diabetes"},{"key":"B39","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1186\/s13059-019-1753-9","article-title":"Screening for genes that accelerate the epigenetic aging clock in humans reveals a role for the H3K36 methyltransferase NSD1","volume":"20","author":"Martin-Herranz","year":"2019","journal-title":"Genome Biol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.biochi.2022.01.005","article-title":"GPR75: An exciting new target in metabolic syndrome and related disorders","volume":"195","author":"Murtaza","year":"2022","journal-title":"Biochimie"},{"key":"B41","doi-asserted-by":"publisher","first-page":"969418","DOI":"10.1155\/2012\/969418","article-title":"17alpha-Ethynyl-androst-5-ene-3beta,7beta,17beta-triol (HE3286) Is Neuroprotective and Reduces Motor Impairment and Neuroinflammation in a Murine MPTP Model of Parkinson's Disease","volume":"2012","author":"Nicoletti","year":"2012","journal-title":"Parkinsons. Dis"},{"key":"B42","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.brainresrev.2008.09.001","article-title":"Toll-like receptors in neurodegeneration","volume":"59","author":"Okun","year":"2009","journal-title":"Brain Res. Rev"},{"key":"B43","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.biochi.2014.05.005","article-title":"DNMT3L interacts with transcription factors to target DNMT3L\/DNMT3B to specific DNA sequences: role of the DNMT3L\/DNMT3B\/p65-NFkappaB complex in the (de-)methylation of TRAF1","volume":"104","author":"Pacaud","year":"2014","journal-title":"Biochimie"},{"key":"B44","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/1750-1326-6-45","article-title":"Microglial phagocytosis induced by fibrillar beta-amyloid is attenuated by oligomeric beta-amyloid: implications for Alzheimer's disease","volume":"6","author":"Pan","year":"2011","journal-title":"Mol. Neurodegener"},{"key":"B45","unstructured":"\u201cEffects of NE3107 anti-inflammatory treatment on motor activity and neurodegenerationative features of Parkinson's disease in a marmoset monkey model,\u201d\n          \n          \n            \n              Philllipens\n              I. H. C. H. M.\n            \n            \n              Ahlem\n              C.\n            \n            \n              Reading\n              C. L.\n            \n          \n          International Congress of Parkinson's Disease and Movement Disorders, Copenhagen, Denmark\n          \n          2023"},{"key":"B46","doi-asserted-by":"publisher","first-page":"2436","DOI":"10.1096\/fj.201902447R","article-title":"A locked immunometabolic switch underlies TREM2 R47H loss of function in human iPSC-derived microglia","volume":"34","author":"Piers","year":"2020","journal-title":"FASEB J"},{"key":"B47","doi-asserted-by":"publisher","first-page":"E6287","DOI":"10.1073\/pnas.1702973114","article-title":"Local destabilization, rigid body, and fuzzy docking facilitate the phosphorylation of the transcription factor Ets-1 by the mitogen-activated protein kinase ERK2","volume":"114","author":"Piserchio","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"B48","doi-asserted-by":"publisher","first-page":"289","DOI":"10.2217\/nmt-2021-0022","article-title":"NM101 Phase III study of NE3107 in Alzheimer's: rationale, design and therapeutic modulation of neuroinflammation and insulin resistance","volume":"11","author":"Reading","year":"2021","journal-title":"Neurodegener. Dis. Manag"},{"key":"B49","doi-asserted-by":"publisher","first-page":"814989","DOI":"10.1155\/2013\/814989","article-title":"An anti-inflammatory sterol decreases obesity-related inflammation-induced insulin resistance and metabolic dysregulation","volume":"2013","author":"Reading","year":"","journal-title":"Mediators Inflamm"},{"key":"B50","doi-asserted-by":"publisher","first-page":"e32147","DOI":"10.1371\/journal.pone.0032147","article-title":"Molecular targets for 17alpha-ethynyl-5-androstene-3beta,7beta,17beta-triol, an anti-inflammatory agent derived from the human metabolome","volume":"7","author":"Reading","year":"2012","journal-title":"PLoS ONE"},{"key":"B51","doi-asserted-by":"crossref","DOI":"10.1002\/alz.071981","article-title":"\u201cTreatment-induced epigenetic modifications in MCI and probable Alzheimer's disease,\u201d","volume-title":"Alzheimer's Association International Conference","author":"Reading","year":"2023"},{"key":"B52","doi-asserted-by":"publisher","first-page":"E343","DOI":"10.1002\/oby.20207","article-title":"A synthetic anti-inflammatory sterol improves insulin sensitivity in insulin-resistant obese impaired glucose tolerance subjects","volume":"21","author":"Reading","year":"","journal-title":"Obesity"},{"key":"B53","doi-asserted-by":"publisher","first-page":"23937","DOI":"10.1074\/jbc.M011564200","article-title":"Neurosteroid hydroxylase CYP7B: vivid reporter activity in dentate gyrus of gene-targeted mice and abolition of a widespread pathway of steroid and oxysterol hydroxylation","volume":"276","author":"Rose","year":"2001","journal-title":"J. Biol. Chem"},{"key":"B54","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.pneurobio.2009.01.001","article-title":"Inflammation in Alzheimer's disease: amyloid-beta oligomers trigger innate immunity defence via pattern recognition receptors","volume":"87","author":"Salminen","year":"2009","journal-title":"Prog. Neurobiol"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1101\/2023.12.21.572866","article-title":"A novel framework to build saliva-based DNA methylation biomarkers: quantifying systemic chronic inflammation as a case study","author":"Schmunk","year":"2023","journal-title":"bioRxiv"},{"key":"B56","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1101\/gad.950902","article-title":"An ERK2 docking site in the Pointed domain distinguishes a subset of ETS transcription factors","volume":"16","author":"Seidel","year":"2002","journal-title":"Genes Dev"},{"key":"B57","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1038\/s41586-024-07501-1","article-title":"A disease-associated gene desert directs macrophage inflammation through ETS2","volume":"630","author":"Stankey","year":"2024","journal-title":"Nature"},{"key":"B58","first-page":"275","article-title":"Phase I and Phase II clinical trials of androst-5-ene-3beta,7beta,17beta-triol","volume":"3","author":"Stickney","year":"2011","journal-title":"Am. J. Transl. Res"},{"key":"B59","doi-asserted-by":"publisher","first-page":"19471","DOI":"10.1038\/s41598-022-21920-y","article-title":"Naturally-aged microglia exhibit phagocytic dysfunction accompanied by gene expression changes reflective of underlying neurologic disease","volume":"12","author":"Thomas","year":"2022","journal-title":"Sci. Rep"},{"key":"B60","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1016\/j.neuron.2008.12.008","article-title":"Genomic anatomy of the hippocampus","volume":"60","author":"Thompson","year":"2008","journal-title":"Neuron"},{"key":"B61","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.neurobiolaging.2008.03.009","article-title":"RANTES upregulation in the Alzheimer's disease brain: a possible neuroprotective role","volume":"31","author":"Tripathy","year":"2010","journal-title":"Neurobiol. Aging"},{"key":"B62","doi-asserted-by":"publisher","first-page":"796","DOI":"10.4103\/1673-5374.295340","article-title":"Regulated upon activation, normal T cell expressed and secreted (RANTES) levels in the peripheral blood of patients with Alzheimer's disease","volume":"16","author":"Vacinova","year":"2021","journal-title":"Neural Regen Res"},{"key":"B63","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1056\/NEJMc2301380","article-title":"Lecanemab in early Alzheimer's disease. Reply","volume":"388","author":"van Dyck","year":"2023","journal-title":"N. Engl. J. Med"},{"key":"B64","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1124\/jpet.109.161182","article-title":"Amelioration of glucose intolerance by the synthetic androstene HE3286: link to inflammatory pathways","volume":"333","author":"Wang","year":"2010","journal-title":"J. Pharmacol. Exp. Ther"},{"key":"B65","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1097\/WAD.0000000000000367","article-title":"Lack of association between the CCR5-delta32 polymorphism and neurodegenerative disorders","volume":"34","author":"Wojta","year":"2020","journal-title":"Alzheimer Dis. Assoc. Disord"},{"key":"B66","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/S0306-4522(03)00438-X","article-title":"Dehydroepiandrosterone 7-hydroxylase CYP7B: predominant expression in primate hippocampus and reduced expression in Alzheimer's disease","volume":"121","author":"Yau","year":"2003","journal-title":"Neuroscience"},{"key":"B67","doi-asserted-by":"publisher","first-page":"e30766","DOI":"10.7554\/eLife.30766.042","article-title":"Dnmt3a is an epigenetic mediator of adipose insulin resistance","volume":"6","author":"You","year":"2017","journal-title":"Elife"}],"updated-by":[{"DOI":"10.3389\/fnins.2025.1758523","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T00:00:00Z","timestamp":1768176000000}}],"container-title":["Frontiers in Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnins.2025.1516746\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T09:45:57Z","timestamp":1768297557000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnins.2025.1516746\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,2]]},"references-count":67,"alternative-id":["10.3389\/fnins.2025.1516746"],"URL":"https:\/\/doi.org\/10.3389\/fnins.2025.1516746","relation":{"has-part":[{"id-type":"doi","id":"https:\/\/doi.org\/10.3389\/fnins.2025.1516746.s001","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.3389\/fnins.2025.1516746.s002","asserted-by":"subject"}]},"ISSN":["1662-453X"],"issn-type":[{"value":"1662-453X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,2]]},"article-number":"1516746"}}